Skip to main content
LAST MILE ENTERPRISES LIMITED logo

LAST MILE ENTERPRISES LIMITED — Investor Relations & Filings

Ticker · 526961 ISIN · INE404B01022 LEI · 984500XC3F6C4FB0AA13 BSE.NS Manufacturing
Filings indexed 10 across all filing types
Latest filing 2026-06-19 Regulatory Filings
Country IN India
Listing BSE.NS 526961

About LAST MILE ENTERPRISES LIMITED

https://lastmileenterprisesltd.com/

Last Mile Enterprises Limited specializes in the design, development, and distribution of therapeutic devices and rehabilitation technologies. The firm focuses on creating assistive solutions that facilitate physical recovery and enhance mobility for patients with various physiological conditions. A primary offering includes the Digit-S, a specialized device engineered for finger rehabilitation that automates therapeutic exercises for individuals recovering from neurological or orthopedic injuries. The company integrates mechanical design with clinical research to produce tools suitable for both institutional healthcare settings and home-based therapy. Its operations center on the commercialization of patented medical innovations aimed at improving patient outcomes through precise, technology-driven rehabilitation protocols.

Recent filings

Filing Released Lang Actions
We wish to inform you that the delay in submission of the audited financial result has occured due to delay in the receipt of financial statements from one of our subsidiary companies. ....
Regulatory Filings Classification · 95% confidence The document is a letter from the Managing Director of Last Mile Enterprises Limited addressed to BSE Limited. It clarifies the reason for the delay in submission of the financial results for the year ended March 31, 2026. The letter references regulatory provisions (SEBI LODR Regulations), mentions the delayed submission, and states the circumstances causing the delay (delay in receipt of audited financial statements from a subsidiary). However, the document itself does not contain financial results, audit reports, or financial data. Instead, it is a regulatory communication clarifying and explaining a delay in filing financial results. The document length is short (2187 characters) and is essentially a disclosure related to regulatory compliance. Therefore, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for such regulatory announcements and clarifications that do not fit into other specific report categories.
2026-06-19 English
Please find enclosed herewith copy of advertisement given in newspaper of the Audited financial results for the quarter and year ended on March 31, 2026.
Report Publication Announcement Classification · 95% confidence The document is a brief letter to the stock exchange notifying them that the company has published an advertisement of its audited quarterly financial results in newspapers, and encloses a copy of that advertisement. It does not contain the financial statements themselves, but simply announces their publication. Under the “menu vs meal” rule, this is a Report Publication Announcement rather than the report itself.
2026-06-08 English
Please find the attached disclosure for appointment of Internal Auditor of the Company.
Board/Management Information Classification · 85% confidence The document is a stock exchange filing under Regulation 30 of SEBI LODR, notifying the outcome of a Board of Directors meeting held 06 June 2026. It covers approvals (audited results, dividend recommendation) and an internal auditor appointment. This is an announcement of board/management decisions rather than the report itself, fitting the "Board/Management Information" category.
2026-06-06 English
Pusuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, please find enclosed the Audited Financial Results along with the Auditor''s Report for the fourth quarter and financial year ....
Interim / Quarterly Report Classification · 79% confidence The document is a formal compliance filing under SEBI LODR Regulation 33 to BSE, including consolidated and standalone audited financial results for the quarter and year ended 31 March 2026. It contains full P&L schedules, balance sheet, cash flow statements, and accompanying audit report. This is not a mere earnings highlight (ER) nor a full annual report (10-K), but a comprehensive periodic financial report filed with the exchange — matching the definition of an Interim/Quarterly Report (IR). FY 2026
2026-06-06 English
The board of Directors on the meeting held on 06th June, 2026, approved the dividend.
Regulatory Filings Classification · 90% confidence The document is a notice to the stock exchange under SEBI Listing Regulations (Regulation 30) disclosing the outcome of a Board meeting – approval of audited results (without providing the numbers), dividend recommendation, and appointment of an internal auditor. It contains no substantive financial statements or detailed results and is not itself a management discussion or earnings release. It is a regulatory compliance announcement, making "Regulatory Filings (RNS)" the appropriate category.
2026-06-06 English
Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, please find enclosed the outcome of the Board Meeting held on 06th June 2026, wherein the directors, inter alia, considered ....
Regulatory Filings Classification · 93% confidence The document is a stock exchange disclosure under Regulation 30 of SEBI LODR announcing the outcome of a board meeting held on June 6, 2026. It informs stakeholders that the board approved audited financial results, recommended a dividend, and appointed an internal auditor. It does not contain the full financial statements themselves but is a regulatory announcement of these actions. Thus, according to the taxonomy, this is a general regulatory filing.
2026-06-06 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.